Abstract 14215: Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors

Muthiah Vaduganathan,Stephen J. Greene,Shuaiqi Zhang,Karen Chiswell,Adam D. DeVore,Javed Butler,Paul A. Heidenreich,Joanna Huang,Michelle M. Kittleson,Karen E. Joynt Maddox,James J. McDermott,Anjali T. Owens,Pamela N. Peterson,Scott D. Solomon,Orly Vardeny,Clyde W. Yancy,Gregg C. Fonarow

Abstract 14215: Mortality and Readmission Among Medicare Beneficiaries Hospitalized for Heart Failure Who Are Treatment Candidates for SGLT-2 Inhibitors

2021

Muthiah Vaduganathan
Stephen J. Greene
Shuaiqi Zhang
Karen Chiswell
Adam D. DeVore
Javed Butler
Paul A. Heidenreich
Joanna Huang
Michelle M. Kittleson
Karen E. Joynt Maddox
James J. McDermott
Anjali T. Owens
Pamela N. Peterson
Scott D. Solomon
Orly Vardeny
Clyde W. Yancy
Gregg C. Fonarow

Background: SGLT2i form the latest pillar in the management of HFrEF and appear effective across a range of patient profiles. There is increasing interest around initiation of SGLT2i during hospita...

Keywords:

Emergency medicine
Pillar
Heart failure
medicare beneficiary
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations